Yung-Yeh Su

9PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 21, 2026
A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC.

|Feb 26, 2026
Mutant Isocitrate Dehydrogenase 1 Sensitizes Intrahepatic Cholangiocarcinoma Cells to MDM2 Inhibitors.

Chien-Tsung Liu, Yung-Yeh Su, Nai-Jung Chiang

|Aug 28, 2024
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.

Ying-Chun Shen, Tsung-Hao Liu, Alan Nicholas

|Jun 10, 2023
The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study.

Yung-Yeh Su, Ying-Jui Chao, Chih-Jung Wang

Pageof 2